4h
Zacks Investment Research on MSNCRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth KnowingCRISPR Therapeutics AG (CRSP) closed the latest trading day at $41.22, indicating a +0.12% change from the previous session's end. This change outpaced the S&P 500's 0.08% gain on the day. On the ...
A team of researchers has identified a mechanism that regulates the production of two different proteins from the same gene.
Like people, bacteria get invaded by viruses. In bacteria, the viral invaders are called bacteriophages, derived from the ...
Bacteria get invaded by viruses called phages.Scientists are studying how bacteria use CRISPR to defend themselves from ...
Cathie Wood’s ARK Invest is taking advantage of the recent dip in Tesla (TSLA) stock by purchasing 9,351 shares through its ARKK ETF (ARKK), ...
Zurcher Kantonalbank Zurich Cantonalbank raised its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 3.0% in ...
Farther Finance Advisors LLC boosted its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 34.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & ...
Secondly, you can get limited access to Deep Research without having to part with your cash, as Google has included it in the ...
Now, Johns Hopkins Medicine scientists say they have shed new light on how bacteria protect themselves from certain phage ...
Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...
Using CRISPR-based engineering methods to prompt stem cells to organize into embryo-like structures, scientists were able to create 'programmable' cellular models of embryos without ever experimenting ...
Gene therapy pioneer Jim Wilson and researcher Kiran Musunuru are using contrasting approaches to overcome “irrational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results